Xy Capital LTD Amgen Inc Call Options Transaction History

Xy Capital LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 01, 2024	SELL	$309.38 - $337.38 $464,070 - $506,070	-1,500 Reduced 42.86%	2,000 $644 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $131,375 - $159,655	500 Added 16.67%	3,500 $1.09 Billion
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $430,192 - $519,296	-1,600 Reduced 34.78%	3,000 $853 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $306,840 - $346,152	1,200 Added 35.29%	4,600 $1.32 Billion
Q3 2023 Nov 01, 2023	BUY	$218.65 - $271.46 $743,410 - $922,963	3,400 New	3,400 $914 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Xy Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Xy Capital LTD with notifications on news.